EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 50 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,664,000 | +77.0% | 320,753 | +127.8% | 0.00% | +50.0% |
| Q3 2021 | $940,000 | +0.9% | 140,793 | +28.4% | 0.00% | 0.0% |
| Q2 2021 | $932,000 | -31.3% | 109,618 | -28.6% | 0.00% | 0.0% |
| Q1 2021 | $1,356,000 | +73.2% | 153,507 | +140.7% | 0.00% | 0.0% |
| Q4 2020 | $783,000 | +42.9% | 63,770 | -5.5% | 0.00% | +100.0% |
| Q3 2020 | $548,000 | +131.2% | 67,472 | +173.1% | 0.00% | 0.0% |
| Q2 2020 | $237,000 | +127.9% | 24,703 | +61.0% | 0.00% | – |
| Q1 2020 | $104,000 | +73.3% | 15,345 | +179.1% | 0.00% | – |
| Q4 2016 | $60,000 | – | 5,498 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,787,091 | $20,462,000 | 6.02% |
| INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $18,315,000 | 3.89% |
| NEXTHERA CAPITAL LP | 263,600 | $3,018,000 | 1.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $4,412,000 | 0.86% |
| RA Capital Management | 354,200 | $4,056,000 | 0.50% |
| DAFNA Capital Management LLC | 35,977 | $412,000 | 0.35% |
| Boxer Capital, LLC | 138,331 | $1,584,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 238,907 | $2,735,000 | 0.15% |
| Monashee Investment Management LLC | 31,500 | $361,000 | 0.14% |
| Lombard Odier Asset Management (USA) Corp | 100,000 | $1,145,000 | 0.11% |